OmRx Oncology, Inc.
Isy Goldwasser is a seasoned executive in the biotechnology and life sciences sectors, currently serving as Chief Executive Officer at OmRx Oncology, Inc. and Calibr Bioventures. Goldwasser's previous roles include Entrepreneur In Residence at Scripps Research, Advisor to CEO at CapsoVision, Inc., and CEO at thync, among other significant positions. Extensive experience includes a leadership tenure at Symyx Technologies, where Goldwasser held roles as CEO, President, and Vice President of Business Development. Educational qualifications include a Master of Science in Chemical Engineering from Stanford University and a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology.
This person is not in any teams
This person is not in any offices
OmRx Oncology, Inc.
OmRx Oncology is a pioneering biopharmaceutical company focused on expanding access to life-saving cancer treatments. Our work begins with OX-4224, a small molecule checkpoint inhibitor designed to overcome barriers in regions where traditional antibody-based immunotherapies are out of reach.